Buy & Sell Novo Nordisk A/S (NVO) – Novo Nordisk A/S Price Today
Aura AI Summary
Key Stats
- $195.36BMarket Cap
- HealthSector
- -12.87%3M Drawdown
- $214.74BEnterprise Value
- 4.19%Dividend Yield
- 37% Buy | 63% SellTrading Activity
- 102 daysTypical Hold Time
Novo Nordisk A/S (NVO) is currently valued at a market capitalization of $195.36B, with an enterprise value of $214.74B. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $81.05, highlighting its annual price range. Over the past three months, Novo Nordisk A/S has recorded a drawdown of -12.87%, reflecting recent price volatility. Novo Nordisk A/S offers a dividend yield of 4.19%, with the most recent dividend of $1.28 paid on 30 Mar 26. On average, investors hold Novo Nordisk A/S for approximately 102 days, indicating typical investor behavior on the platform.
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Most Recent News
Global generic drug market to nearly double to $926.54B by 2034 with 6.55% CAGR driven by cost and chronic disease demand
The global generic drug market is projected to grow from USD 519.11 billion in 2025 to USD 926.54 billion by 2034, at a compound annual growth rate (CAGR) of 6.55%. This growth is driven by increasing demand for cost-effective medicines amid rising c...

Investigation launched into Verra Mobility over possible securities fraud linked to contract disclosure.
Ademi LLP is investigating Verra Mobility for potential securities fraud related to inaccurate statements about its financials and business operations. The probe centers on Verra Mobility's failure to timely disclose contract negotiations with Avis B...

Sivers Semiconductors secures $8.2M order from ALL.SPACE for 2027 Ka-band beamforming ICs.
Sivers Semiconductors received an $8.2 million production order from ALL.SPACE for 2027, supplying multi-beam Ka-band beamforming integrated circuits critical for next-gen multi-orbit satellite communications. This order highlights Sivers' expanding ...
